Kim Mulholland MB BS FRACP MD
- Room G18
- LSHTM
- Keppel Street
- London
- WC1E 7HT
- T: +44 207 927 2498
I am an Australian paediatrician, but I have spent much of my career working in the developing world, particularly Sudan and Gambia.I entered the vaccine research field with a series of trials of Hib vaccine in Gambian infants and pregnant women.This work culminated in the Gambia Hib trial (1993-96).That study demonstrated the power of large vaccine trials to inform us about the contribution of an organism, in that case Hib, to the overall burden of pneumonia.In the subsequent years, while working for WHO, I was involved in the design of most pneumococcal or Hib vaccine trials undertaken in the developing world, and in the establishment of clinical, radiological and microbiological standards for pneumococcal vaccine trials.Currently I share my time between LSHTM, where I have been one of the leaders of the Hib Initiative, and Menzies School of Health Research in Darwin, Australia, from where I am involved in a range of Hib, pneumococcal, Dengue fever and HPV vaccine studies. I also lead the Menzies component of the AusAID Women’s and Children’s Health Knowledge Hub, which is focused on nutrition and its relationship to maternal and infant survival.
Affiliation
Teaching
I am directly involved in teaching in the areas of child survival, epidemiology, tropical nursing, tropical medicine, vaccinology and health policy.
Research
I am involved in the evaluation of the following vaccines: pneumococcal, Hib, Dengue Fever, and Group B meningococcal vaccines.
I am also involved in research into: pneumonia, neonatal mortality, malnutrition, and access to health services.
Research areas
- Child health
- Maternal health
- Perinatal health
- Vaccines
Disciplines
- Medicine
Disease and Health Conditions
- Malnutrition
Other interests
- Child Survival
- Pneumococcal Vaccines
- Pneumonia
-
Selected publications
-
Hyporesponsiveness to re-challenge dose following pneumococcal polysaccharide vaccine at 12 months of age, a randomized controlled trial
Russell, F.M.; Carapetis, J.R.; Balloch, A.; Licciardi, P.V.; Jenney, A.W.J.; Tikoduadua, L.; Waqatakirewa, L.; Pryor, J.; Nelson, J.; Byrnes, G.B.; Cheung, Y.B.; Tang, M.L.K.; Mulholland, E.K.
Vaccine, 2010; 28(19):3341-3349
-
Confidence in vaccines in developing countries: social, cultural, economic and political influences.
Mulholland, K.; Korczak, V.; Tangcharoensathien, V.;
J Epidemiol Community Health, 2010;
-
INVASIVE PNEUMOCOCCAL DISEASE IN FIJI: CLINICAL SYNDROMES, EPIDEMIOLOGY, AND THE POTENTIAL IMPACT OF PNEUMOCOCCAL CONJUGATE VACCINE.
Russell, F.M.; Carapetis, J.R.; Tikoduadua, L.; Chandra, R.; Seduadua, A.; Satzke, C.; Pryor, J.; Buadromo, E.; Waqatakirewa, L.; Mulholland, E.K.;
Pediatr Infect Dis J, 2010;
-
Developing sustainable funding for vaccine safety infrastructure.
Mulholland, K.; Halsey, N.A.; Black, S.;
Vaccine, 2009; 28(5):1133-4
-
Equity and child-survival strategies.
Mulholland, E.; Smith, L.; Carneiro, I.; Becher, H.; Lehmann, D.;
Bull World Health Organ, 2008; 86(5):399-407
-
Childhood pneumonia mortality--a permanent global emergency.
Mulholland, K.;
Lancet, 2007; 370(9583):285-9
-
Standardized interpretation of paediatric chest radiographs for the diagnosis of pneumonia in epidemiological studies.
Cherian, T.; Mulholland, E.K.; Carlin, J.B.; Ostensen, H.; Amin, R.; de Campo, M.; Greenberg, D.; Lagos, R.; Lucero, M.; Madhi, S.A.; O'Brien, K.L.; Obaro, S.; Steinhoff, M.C.;
Bull World Health Organ, 2005; 83(5):353-9
-
Kim Mulholland--drawing together the pieces of international child health.
Mulholland, K.;
Lancet Infect Dis, 2001; 1(3):203-9
- → View all Kim Mulholland's publications
